Amgen, Inc. vs Cloudflare Inc — how do they compare? Amgen, Inc. trades at $412.77 (market cap $224.14B), while Cloudflare Inc trades at $306.89 (market cap $109.31B). The key difference: Amgen, Inc. is far larger — about 2.1× Cloudflare Inc's market cap, and Amgen, Inc. pays a 2.43% dividend while Cloudflare Inc pays none. Which is the better fit depends on your goals.
| AMGN | NET | |
|---|---|---|
Market Cap | $224.14B | $109.31B |
Sector | Health | Technology |
52-Week High | $417.20 | $310.40 |
52-Week Low | $271.18 | $160.16 |
Enterprise Value | $267.45B | $108.67B |
Dividend Yield | 2.43% | — |
Trailing returns across standard periods
Latest headlines on both assets
Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amgevita (biosimilar Humira).
Read more on AMGN →Cloudflare is a software company based in San Francisco, California, that offers security and web performance offerings by utilizing a distributed, serverless content delivery network, or CDN. The firm's edge computing platform, Workers, leverages this network by providing clients the ability to deploy, and execute code without maintaining servers.
Read more on NET →